Q Therapeutics, Inc. 4
4 · Q Therapeutics, Inc. · Filed Mar 13, 2014
Insider Transaction Report
Form 4
Q Therapeutics, Inc.[NONE]
EPPSTEIN DEBORAH ANNE
CEO & President, Director
Transactions
- Award
Option to Purchase Common Stock
2014-03-11$0.70/sh+275,000$192,500→ 2,308,071 totalExercise: $0.70From: 2014-03-11Exp: 2024-03-10→ Common Stock (275,000 underlying) - Award
Option to Purchase Common Stock
2014-03-11$0.70/sh+250,000$175,000→ 2,308,071 totalExercise: $0.70From: 2014-03-11Exp: 2024-03-10→ Common Stock (250,000 underlying) - Award
Option to Purchase Common Stock
2014-03-11$0.70/sh+135,594$94,916→ 2,308,071 totalExercise: $0.70From: 2014-03-11Exp: 2024-03-10→ Common Stock (135,594 underlying)
Footnotes (3)
- [F1]Grant relates to the 2013 annual employee grant. Upon grant, 72,917 options immediately vest and are exercisable, with 177,083 options vesting equally over the remaining 34 months.
- [F2]Grant relates to the 2014 annual employee grant. Upon grant, 11,458 options immediately vest and are exercisable, with 263,542 options vesting equally over the remaining 46 months.
- [F3]Grant relates to compensation resulting from the executive's salary deferral that occurred in 2013. All options fully vested upon grant.